Cargando…

Transient Asystole after Sugammadex Administration for Immediate Reversal of Deep Blockade while on Dexmedetomidine Infusion in a Super Obese Patient

Sugammadex is increasingly used to reverse aminosteroid neuromuscular blocking agents. Dosing is calculated based on actual body weight, even for those who are obese. We report a case where a super obese patient (BMI 58.5 kg/m(2)) developed asystole, following coadministration with dexmedetomidine,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gajewski, Michal, Esochaghi, Sorochi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6556339/ https://www.ncbi.nlm.nih.gov/pubmed/31263603 http://dx.doi.org/10.1155/2019/2709568

Ejemplares similares

Bradycardia Leading to Asystole Following Dexmedetomidine Infusion during Cataract Surgery: Dexmedetomidine-Induced Asystole for Cataract Surgery
por: Aikaterini, Amaniti, et al.
Publicado: (2018)

Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient
por: Fierro, Carmen, et al.
Publicado: (2021)

Corrigendum to “Bradycardia Leading to Asystole Following Dexmedetomidine Infusion during Cataract Surgery: Dexmedetomidine-Induced Asystole for Cataract Surgery”
por: Amaniti, Aikaterini, et al.
Publicado: (2019)

Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death
por: Mirza, Kazim, et al.
Publicado: (2020)

Severe bradycardia and asystole associated with sugammadex: case report
por: Oliveira, Catarina, et al.
Publicado: (2019)

Vasovagal Syncope and Transient Asystole During Peripheral Nerve Blockade
por: DeLeon, Alexander M, et al.
Publicado: (2023)

Clinical Impact of Sugammadex in the Reversal of Neuromuscular Blockade
por: Goodner, Joshua A, et al.
Publicado: (2021)

Asystole Following Neuromuscular Blockade Reversal in Cardiac Transplant Patients
por: Nkemngu, Njinkeng J
Publicado: (2017)

Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives
por: Carron, Michele, et al.
Publicado: (2017)

Cardiac arrest after administration of sugammadex as neuromuscular blockade reversal agent and full recovery from anesthesia
por: Samara, Evangelia, et al.
Publicado: (2020)

Reversal by Sugammadex
por: Bajaj, Pramila
Publicado: (2009)

Comment on Fierro et al. Severe Hypotension, Bradycardia and Asystole after Sugammadex Administration in an Elderly Patient. Medicina 2021, 57, 79
por: Sagliocco, Orlando, et al.
Publicado: (2022)

Neuromuscular Blockade Agents Reversal with Sugammadex Compared to Neostigmine in the Living Kidney Donors
por: Quang, Thuy Luu, et al.
Publicado: (2019)

Asystole-induced Bradycardia by Dexmedetomidine during Endoscopic Submucosal Dissection
por: Yamasaki, Tomoaki, et al.
Publicado: (2022)

Prolonged neuromuscular blockade and insufficient reversal after sugammadex administration in cesarean section under general anesthesia: a case report
por: Moriwaki, Kuniaki, et al.
Publicado: (2019)

Negative Pressure Pulmonary Edema after Reversing Rocuronium-Induced Neuromuscular Blockade by Sugammadex
por: Suzuki, Manzo, et al.
Publicado: (2014)

Rocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects
por: Wu, Xinmin, et al.
Publicado: (2014)

Sugammadex, a Neuromuscular Blockade Reversal Agent, Causes Neuronal Apoptosis in Primary Cultures
por: Palanca, José M., et al.
Publicado: (2013)

Sugammadex versus neostigmine reversal of moderate rocuronium-induced neuromuscular blockade in Korean patients
por: Woo, Tiffany, et al.
Publicado: (2013)

Sugammadex to Reverse Neuromuscular Blockade in a Child with a Past History of Cardiac Transplantation
por: Miller, Karen, et al.
Publicado: (2017)

Sugammadex to reverse neuromuscular blockade and provide optimal conditions for motor-evoked potential monitoring
por: Trifa, Mehdi, et al.
Publicado: (2017)

Economic analysis of sugammadex versus neostigmine for reversal of neuromuscular blockade for laparoscopic surgery in China
por: Ren, Maodong, et al.
Publicado: (2020)

Alternating asystole and atrial fibrillation after infusion of propofol and remifentanil with target-controlled infusion
por: Hwang, Won-jung, et al.
Publicado: (2014)

Should we Routinely Reverse Neuromuscular Blockade with Sugammadex in Patients with a History of Heart Transplantation?
por: Yuki, Koichi, et al.
Publicado: (2020)

Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain
por: Martinez-Ubieto, J., et al.
Publicado: (2021)

An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant
por: Paredes, Stephania, et al.
Publicado: (2023)

Asystole after Orthotopic Lung Transplantation: Examining the Interaction of Cardiac Denervation and Dexmedetomidine
por: Webb, Christopher Allen-John, et al.
Publicado: (2012)

β-adrenergic-receptor-antagonists/dexmedetomidine: Recurrent asystole and syncope: case report
Publicado: (2022)

The combination of sugammadex and neostigmine can reduce the dosage of sugammadex during recovery from the moderate neuromuscular blockade
por: Cheong, Soon Ho, et al.
Publicado: (2015)

Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
por: Aouad, Marie T., et al.
Publicado: (2017)

Introduction of sugammadex as standard reversal agent: Impact on the incidence of residual neuromuscular blockade and postoperative patient outcome
por: Ledowski, Thomas, et al.
Publicado: (2013)

Reversal of rocuronium induced neuromuscular blockade using sugammadex in a patient with eclampsia treated by magnesium intraoperatively
por: Song, Sejin, et al.
Publicado: (2014)

Effects of dexamethasone and hydrocortisone on rocuroniuminduced neuromuscular blockade and reversal by sugammadex in phrenic nerve-hemidiaphragm rat model
por: Choi, Heyran, et al.
Publicado: (2019)

The efficacy and safety of sugammadex for reversing postoperative residual neuromuscular blockade in pediatric patients: A systematic review
por: Liu, Guangyu, et al.
Publicado: (2017)

Sugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: A systematic review and meta-analysis
por: Won, Young Ju, et al.
Publicado: (2016)

A retrospective study of sugammadex for reversal of neuromuscular blockade induced by rocuronium in critically ill patients in the ICU
por: Bologheanu, Răzvan, et al.
Publicado: (2022)

Unexpected delayed reversal of rocuronium-induced neuromuscular blockade by sugammadex: A case report and review of literature
por: Wang, Hao-Chen, et al.
Publicado: (2022)

Reversal of rocuronium‐induced intense neuromuscular blockade by sugammadex in Korean children: A pharmacokinetic and pharmacodynamic analysis
por: Ji, Sang‐Hwan, et al.
Publicado: (2022)

Conventional reversal of rocuronium-induced neuromuscular blockade by sugammadex in Korean children: pharmacokinetics, efficacy, and safety analyses
por: Ji, Sang-Hwan, et al.
Publicado: (2023)

Commentary on “An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant”
por: Chowdhury, Sumit Roy, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r95rjj9eikra9np5el15k1vpt5